Skip to search formSkip to main contentSkip to account menu

Cytarabine-Daunorubicin Regimen

Known as: 7-3 Induction Regimen, AraC-Daunorubicin Regimen, 5-2 Consolidation Regimen 
A regimen consisting of cytarabine and daunorubicin used as both as induction and consolidation (post remission) treatment for acute myeloid leukemia… 
National Institutes of Health

Related topics

Related topics

5 relations
Adult Acute Myeloblastic LeukemiaCytarabineDaunorubicin Hydrochloridecytarabine/daunorubicin protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis
Serum α-fetoprotein- (AFP-) elevated gastric cancer is a rare tumor that has a poor prognosis due to high incidence of liver… 
2013
2013
Bfr (bendamustine, fludarabine, rituximab) Vs. FCR Nonmyeloablative Allogeneic Conditioning In Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Outcome Results Including Minimal Residual…
Background Bendamustine is a novel active agent in CLL with favorable safety profile. We have previously reported the outcomes of… 
2004
2004
Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma
Purpose Intrahepatic cholangiocarcinoma usually presents late in the clinical course and has a poor prognosis. No effective… 
2004
2004
EMA‐EP regimen, as firstline multiple agent chemotherapy in high‐risk GTT patients (stage II–IV)
Multiple agent chemotherapy in high-risk metastatic gestational trophoblastic tumor patients is a problem for any medical team… 
2001
2001
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer
In advanced gastric cancer, we investigated feasibility and activity of sequential chemotherapy with docetaxel after an intensive… 
2000
2000
Long term (five-year) survival following radical surgical treatment plus adjuvant chemotherapy (FAM) in advanced gastric cancer: a controlled study.
Several drugs and their associations are being used for adjuvant or complementary chemotherapy with the aim of improving results… 
2000
2000
Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
AbstractBackground. The effect of low-dose 5-fluorouracil (FU) and cisplatin therapy (FP regimen) against metastatic breast… 
1995
1995
A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma.
Thirty-four adults with malignant lymphoma at high-risk for relapse were treated on a Phase I-II study of high-dose thiotepa… 
1992
1992
Intensive chemotherapy for peripheral T‐cell lymphomas
Forty‐two patients with previously untreated peripheral T‐cell lymphomas (PTCL) were treated with an intensive chemotherapy… 
Review
1990
Review
1990
Malignant tumours of the stomach.
The commonest malignant tumour of the stomach is gastric carcinoma. Although the incidence of this neoplasm has declined… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)